Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases
Author:
Affiliation:
1. Faculty of Pharmaceutical Sciences, UCSI University, Taman Connaught, Cheras, Kuala Lumpur, 56000, Malaysia
2. Institute of Pharmaceutical Research, GLA University, NH-2, P.O. Chaumuhan, Mathura, 281406, Uttar Pradesh, India
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Reference136 articles.
1. Lu X.; Block T.; Study of the early steps of the Hepatitis B virus life cycle. Int J Med Sci 2004,1(1),21-33
2. Goto T.; Nakai M.; Ikuta K.; The life-cycle of human immunodeficiency virus type 1. Micron 1998,29(2-3),123-138
3. Cann A.J.; Karn J.; Molecular biology of HIV. AIDS 1989,3(Suppl.),S19-S34
4. Noreña I.; Fernández-Ruiz M.; Aguado J.M.; Viral infections in the biologic therapy era. Expert Rev Anti Infect Ther 2018,16(10),781-791
5. 10 global health issues to track in 2021 World Health Organization (WHO)Available from: (Accessedon: 31/02/2022).2021
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface;Journal of Computer-Aided Molecular Design;2024-01-24
2. Meridine and Xestosaprol M have Potential Anti-Virus Resembling Remdesivir;Research Journal of Pharmacy and Technology;2023-09-30
3. Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein;Viruses;2023-07-17
4. Bioactive compounds screening of Rafflesia sp. and Sapria sp. (Family: Rafflesiaceae) as anti-SARS-CoV-2 via tetra inhibitors: An in silico research;Journal of Pharmacy & Pharmacognosy Research;2023-07-01
5. Advances in Drug Discovery based on Genomics, Proteomics and Bioinformatics (Part III);Current Topics in Medicinal Chemistry;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3